Equels Thomas K (CIK 1450324) reported 9 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-18). Recent activity: Buy AIM (24,000 shares), Buy AIM (11,000 shares), Buy AIM (22,000 shares), Buy AIM (5,900 shares), Buy AIM (25,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-18 | AIM ImmunoTech Inc. (AIM) | CEO & President | Buy | 24,000 | $4,992 |
| 2026-09-17 | AIM ImmunoTech Inc. (AIM) | CEO & President | Buy | 11,000 | $2,310 |
| 2026-09-16 | AIM ImmunoTech Inc. (AIM) | CEO & President | Buy | 22,000 | $4,862 |
| 2026-09-15 | AIM ImmunoTech Inc. (AIM) | CEO & President | Buy | 5,900 | $1,292 |
| 2026-03-16 | AIM ImmunoTech Inc. (AIM) | CEO & President | Buy | 25,000 | $0 |
| 2025-06-16 | AIM ImmunoTech Inc. (AIM) | CEO & President | Buy | 107 | $824 |
| 2025-06-13 | AIM ImmunoTech Inc. (AIM) | CEO & President | Buy | 103 | $896 |
| 2025-04-23 | AIM ImmunoTech Inc. (AIM) | CEO & President | Buy | 2.0M | $59,055 |
| 2025-04-07 | AIM ImmunoTech Inc. (AIM) | CEO & President | Buy | 41,000 | $2,460 |
来源：SEC Form 4 申报文件 · 截至 2026-09-18